208 related articles for article (PubMed ID: 9283948)
1. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. V. Localization of higher 5 alpha-reductase activity to the reproductive tract in oligozoospermic men administered supraphysiological doses of testosterone.
Anderson RA; Kelly RW; Wu FC
J Androl; 1997; 18(4):366-71. PubMed ID: 9283948
[TBL] [Abstract][Full Text] [Related]
2. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone.
Anderson RA; Wallace AM; Wu FC
J Clin Endocrinol Metab; 1996 Mar; 81(3):902-8. PubMed ID: 8772548
[TBL] [Abstract][Full Text] [Related]
3. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
Wallace EM; Gow SM; Wu FC
J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
[TBL] [Abstract][Full Text] [Related]
4. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. II. Pharmacokinetics and pharmacodynamics of once weekly administration of testosterone enanthate.
Anderson RA; Wu FC
J Clin Endocrinol Metab; 1996 Mar; 81(3):896-901. PubMed ID: 8772547
[TBL] [Abstract][Full Text] [Related]
5. Suppression of spermatogenesis by testosterone enanthate in Thai men.
Aribarg A; Sukcharoen N; Chanprasit Y; Ngeamvijawat J; Kriangsinyos R
J Med Assoc Thai; 1996 Oct; 79(10):624-9. PubMed ID: 8996996
[TBL] [Abstract][Full Text] [Related]
6. Suppression of human spermatogenesis by testosterone implants.
Handelsman DJ; Conway AJ; Boylan LM
J Clin Endocrinol Metab; 1992 Nov; 75(5):1326-32. PubMed ID: 1430094
[TBL] [Abstract][Full Text] [Related]
7. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
[TBL] [Abstract][Full Text] [Related]
8. Contraceptive efficacy and adverse effects of testosterone enanthate in Thai men.
Sukcharoen N; Aribarg A; Kriangsinyos R; Chanprasit Y; Ngeamvijawat J
J Med Assoc Thai; 1996 Dec; 79(12):767-73. PubMed ID: 9071080
[TBL] [Abstract][Full Text] [Related]
9. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
[TBL] [Abstract][Full Text] [Related]
10. Androgens in seminal plasma: markers of the surface epithelium of the male reproductive tract.
Zalata A; Hafez T; Verdonck L; Vermeulen L; Comhaire F
Int J Androl; 1995 Oct; 18(5):271-7. PubMed ID: 8567098
[TBL] [Abstract][Full Text] [Related]
11. Comparison between testosterone oenanthate-induced azoospermia and oligozoospermia in a male contraceptive study. IV. Suppression of endogenous testicular and adrenal androgens.
Anderson RA; Wallace AM; Kicman AT; Wu FC
Hum Reprod; 1997 Aug; 12(8):1657-62. PubMed ID: 9308789
[TBL] [Abstract][Full Text] [Related]
12. Higher testosterone dose impairs sperm suppression induced by a combined androgen-progestin regimen.
Meriggiola MC; Costantino A; Bremner WJ; Morselli-Labate AM
J Androl; 2002; 23(5):684-90. PubMed ID: 12185103
[TBL] [Abstract][Full Text] [Related]
13. Suppression of spermatogenesis in man induced by Nal-Glu gonadotropin releasing hormone antagonist and testosterone enanthate (TE) is maintained by TE alone.
Swerdloff RS; Bagatell CJ; Wang C; Anawalt BD; Berman N; Steiner B; Bremner WJ
J Clin Endocrinol Metab; 1998 Oct; 83(10):3527-33. PubMed ID: 9768659
[TBL] [Abstract][Full Text] [Related]
14. Suppression of spermatogenesis with desogestrel and testosterone pellets is not enhanced by addition of finasteride.
Kinniburgh D; Anderson RA; Baird DT
J Androl; 2001; 22(1):88-95. PubMed ID: 11191092
[TBL] [Abstract][Full Text] [Related]
15. Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach.
Bebb RA; Anawalt BD; Christensen RB; Paulsen CA; Bremner WJ; Matsumoto AM
J Clin Endocrinol Metab; 1996 Feb; 81(2):757-62. PubMed ID: 8636300
[TBL] [Abstract][Full Text] [Related]
16. Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens.
Bagatell CJ; Matsumoto AM; Christensen RB; Rivier JE; Bremner WJ
J Clin Endocrinol Metab; 1993 Aug; 77(2):427-32. PubMed ID: 8345047
[TBL] [Abstract][Full Text] [Related]
17. Depot testosterone with etonogestrel implants result in induction of azoospermia in all men for long-term contraception.
Brady BM; Walton M; Hollow N; Kicman AT; Baird DT; Anderson RA
Hum Reprod; 2004 Nov; 19(11):2658-67. PubMed ID: 15333595
[TBL] [Abstract][Full Text] [Related]
18. A lower dosage levonorgestrel and testosterone combination effectively suppresses spermatogenesis and circulating gonadotropin levels with fewer metabolic effects than higher dosage combinations.
Anawalt BD; Bebb RA; Bremner WJ; Matsumoto AM
J Androl; 1999; 20(3):407-14. PubMed ID: 10386821
[TBL] [Abstract][Full Text] [Related]
19. Is high dosage testosterone an effective male contraceptive agent?
Matsumoto AM
Fertil Steril; 1988 Aug; 50(2):324-8. PubMed ID: 3396702
[TBL] [Abstract][Full Text] [Related]
20. Progress in research into new methods of fertility regulation for men.
Prog Hum Reprod Res; 1995; (33):2. PubMed ID: 12289975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
